Circle of knowledge

Free template - religious exemption

NEW: Finland pauses use of Moderna's COVID-19 vaccine for young men due to risk of heart inflammation.

https://www.reuters.com/world/europe/finland-pauses-use-moderna-covid-19-vaccine-young-men-2021-10-07/

@KanekoaTheGreat

Singapore flattened the curve.

STOP PRESS:
Iceland’s government halts ALL use of the Moderna covid19 vaccine, noted obvious excess of myocarditis.

This is strange. The Pfizer product is associated with higher incidence of myocarditis.

Best wishes
Mike


Article Translated to English

The Chief Epidemiologist has decided that the Moderna vaccine against Covid-19 will not be used in Iceland while further information is obtained on the safety of the vaccine during booster vaccinations.

An announcement states that in recent days there has been data from the Nordic countries on the increased incidence of myocarditis and pericarditis after vaccination with the Moderna vaccine in addition to the Pfizer / BioNTech vaccine.

According to the epidemiologist, the Moderna vaccine has for the past two months been used almost exclusively here for booster vaccinations after the Janssen vaccine and after two-dose vaccinations for the elderly and immunocompromised. Very few individuals are said to have received the second dose of the basic vaccine that started with Moderna.

Sufficient supply of Pfizer

In Sweden, the use of Moderna has been restricted to individuals born before 1991. In Norway and Denmark, it has been emphasized that the Pfizer vaccine is recommended rather than Moderna for 12 to 17 year olds.

In Iceland, only the Pfizer vaccine has been recommended for primary vaccination at 12 to 17 years of age since the vaccination of the age group began.

According to the Chief Epidemiologist, the decision was made to wait with the use of Moderna as there is a sufficient supply of Pfizer vaccine for booster vaccinations of defined priority groups and basic vaccinations of those who have not yet been vaccinated.

https://www.visir.is/g/20212167101d/stodva-notkun-boluefnis-moderna-her-a-landi-i-ljosi-nyrra-gagna

LOCKDOWNS INCREASE TRANSMISSION OF RESPIRATORY VIRUSES, THEY DO NOT DECREASE CASES

"In the framework of this analysis, there is no evidence that more restrictive nonpharmaceutical interventions (‘lockdowns’) contributed substantially to bending the curve of new cases in England, France, Germany, Iran, Italy, the Netherlands, Spain or the United States in early 2020. By comparing the effectiveness of NPIs on case growth rates in countries that implemented more restrictive measures with those that implemented less-restrictive measures, the evidence points away from indicating that mrNPIs provided additional meaningful benefit above and beyond lrNPIs. While modest decreases in daily growth (under 30%) cannot be excluded in a few countries, the possibility of large decreases in daily growth due to mrNPIs is incompatible with the accumulated data.

The direction of the effect size in most scenarios points towards an increase in the case growth rate, though these estimates are only distinguishable from zero in Spain (consistent with nonbeneficial effect of lockdowns). Only in Iran do the estimates consistently point in the direction of additional reduction in the growth rate, yet those effects are statistically indistinguishable from zero.

While it is hard to draw firm conclusions from these estimates, they are consistent with a recent analysis that identified increased population-level transmission and cases in Hunan, China, during the period of stay-at-home orders, attributed to increased intra-household density and transmission.

In other words, it is possible that stay-at-home orders may facilitate transmission if they increase person-to-person contact where transmission is efficient such as closed spaces. "

https://onlinelibrary.wiley.com/doi/full/10.1111/eci.13484

Florian Dagoury, the current world's top static breath-hold freediver - he officially held his breath for 10 minutes and 30 seconds - has been diagnosed with myocarditis and pericarditis 40 days after his second dose with the Pfizer vaccine.

He has seen his health and performance gravely impaired with his heart rate while asleep nearly doubling from 37-45 bpm to 65-70 bpm and he is now "struggling to reach 8 min breath holds" with roughly a "30% decrease" on his diving performance.

https://www.instagram.com/p/CUrJkJ-FuFd/

@KanekoaTheGreat

Around 80% of the adult population of Vermont, USA is fully vaccinated against Covid-19, and it is the most vaccinated state in the USA.

But despite this the state is currently experiencing a huge surge in new hospitalisations for Covid-19 that is comparable to the levels seen during winter 2020/2021…

https://theexpose.uk/2021/10/09/most-vaccinated-state-in-the-usa-sees-huge-surge-in-covid-19-hospitalisations/

In less than a year Covid-19 injection deaths are over 92 times all other vaccine deaths reported by VAERS in the 1990’s and more than 40 times the combined deaths reported in the last decade from ALL vaccines administered to all groups.

Source of the data: https://openvaers.com/covid-data

“Boys between 16 and 19 years of age had the highest incidence of myocarditis after the second dose . . . The risk of heart problems in boys of that age was about nine times higher than in unvaccinated boys of the same age.”

https://technofog.substack.com/p/why-is-pfizer-pushing-an-untested

2005: "Gary Nabel of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, and his co-workers injected mice with spike protein from a SARS virus taken from a human patient infected in early 2003. They then collected the antibodies the animals produced.

In lab experiments, they showed that these antibodies were unable to attack spike protein from a different strain of SARS, isolated from a patient infected in late 2003.

The team next tested whether the antibodies would attack spike proteins from two SARS strains isolated from civets, from which the virus is thought to have originally jumped into humans. In this case, they found hints that the antibodies actually boosted the ability of the virus to infect cells. The study is published in the Proceedings of the National Academy of Science1."

https://www.nature.com/articles/news050110-3#ref-CR1